'''Clazolam'''<ref>NL Patent 6510987</ref> ('''SAH-1123'''), also referred to as '''isoquinazepon''', is a [[drug]] which is a fused [[benzodiazepine]] and [[tetrahydroisoquinoline]] derivative.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA476&dq=clazolam&pg=PA476#v=onepage&q=clazolam&f=false}}</ref> It was developed in the 1960s but was never marketed.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA476&dq=clazolam&pg=PA476#v=onepage&q=clazolam&f=false}}</ref> It possesses [[anxiolytic]] effects and is also claimed to have [[antidepressant]] properties.<ref name="isbn0-412-46630-9">{{cite book | author = David J. Triggle | title = Dictionary of pharmacological agents | publisher = Chapman & Hall | location = London | year = 1997 | pages = | isbn = 0-412-46630-9 | oclc = | doi = | url = https://books.google.com/books?id=DeX7jgInYFMC&lpg=PA476&dq=clazolam&pg=PA476#v=onepage&q=clazolam&f=false}}</ref><ref name="doi10.1070/RC2009v078n06ABEH004041">{{cite journal | author = Potikha LM, Kovtunenko VA | title = Synthesis and properties of 3-aminodihydroisoquinolines | journal = Russian Chemical Reviews | volume = 78 | issue = 6 | pages = 513â€“533 | year = 2009 | pmid = | doi = 10.1070/RC2009v078n06ABEH004041 | url = http://www.turpion.org/php/paper.phtml?journal_id=rc&paper_id=4041}}</ref>
